Comparison of Nodal versus Primary Her2/neu Expression in Node-positive Breast Cancer Patients

被引：0
|
作者：
Lago-Toro, C. E. [1 ]
Grujic, E. [2 ]
Larsen, A. R. [1 ]
Allen, L. [1 ]
Barrio, A. V. [1 ]
Sieling, B. [3 ]
Fancher, T. [3 ]
Frazier, T. G. [1 ]
机构：
[1] Bryn Mawr Hosp, Dept Breast Surg, Bryn Mawr, PA USA
[2] Bryn Mawr Hosp, Dept Pathol, Bryn Mawr, PA USA
[3] St Marys Hosp, Dept Breast Surg, Waterbury, CT USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] HER2 and response to paclitaxel in node-positive breast cancer
    Nash, Irwin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02): : 198 - 198
  • [2] HER2 and response to paclitaxel in node-positive breast cancer
    Hayes, Daniel F.
    Thor, Ann D.
    Dressler, Lynn G.
    Weaver, Donald
    Edgerton, Susan
    Cowan, David
    Broadwater, Gloria
    Goldstein, Lori J.
    Martino, Silvana
    Ingle, James N.
    Henderson, I. Craig
    Norton, Larry
    Winer, Eric P.
    Hudis, Clifford A.
    Ellis, Matthew J.
    Berry, Donald A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1496 - 1506
  • [3] Comparison of immunological responses in node-positive and node-negative breast cancer patients receiving a HER2/neu E75 peptide vaccine
    M. T. Hueman
    J. M. Gurney
    C. E. Storrer
    L. Kotula
    K. Jackson
    M. Wilson
    C. D. Shriver
    S. Ponnian
    G. E. Peoples
    [J]. Annals of Surgical Oncology, 2004, 11 : S69 - S70
  • [4] Comparison of immunological responses in node-positive and node-negative breast cancer patients receiving a HER2/neu E75 peptide vaccine
    Hueman, MT
    Gurney, JM
    Storrer, CE
    Kotula, L
    Jackson, K
    Wilson, M
    Shriver, CD
    Ponniah, S
    Peoples, GE
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S69 - S70
  • [5] HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer
    Schoppmann, S. F.
    Tamandl, D.
    Roberts, L.
    Jomrich, G.
    Schoppmann, A.
    Zwrtek, R.
    Dubsky, P.
    Gnant, M.
    Jakesz, R.
    Birner, P.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (05) : 955 - 960
  • [6] c-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu
    Lengyel, E
    Prechtel, D
    Resau, JH
    Gauger, K
    Welk, A
    Lindemann, K
    Salanti, G
    Richter, T
    Knudsen, B
    Woude, GFV
    Harbeck, N
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) : 678 - 682
  • [7] PROGNOSTIC-SIGNIFICANCE OF HER-2/NEU ONCOPROTEIN EXPRESSION IN NODE-POSITIVE BREAST-CANCER
    TETU, B
    BRISSON, J
    POTVIN, D
    MARTEL, D
    [J]. LABORATORY INVESTIGATION, 1993, 68 (01) : A20 - A20
  • [8] HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer
    Berry, DA
    Muss, HB
    Thor, AD
    Dressler, L
    Liu, ET
    Broadwater, G
    Budman, DR
    Henderson, IC
    Barcos, M
    Hayes, D
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3471 - 3479
  • [9] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    [J]. BMC CANCER, 2022, 22 (01)
  • [10] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Yoshiya Horimoto
    Yumiko Ishizuka
    Yuko Ueki
    Toru Higuchi
    Atsushi Arakawa
    Mitsue Saito
    [J]. BMC Cancer, 22
12345